Analystreport

Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating.

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com